Skip to main content

News about Scitation

In December 2016 Scitation will launch with a new design, enhanced navigation and a much improved user experience.

To ensure a smooth transition, from today, we are temporarily stopping new account registration and single article purchases. If you already have an account you can continue to use the site as normal.

For help or more information please visit our FAQs.

banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
/content/aip/journal/adva/5/8/10.1063/1.4926584
1.
1.R. Yuste, Nature methods 2(12), 902-904 (2005).
http://dx.doi.org/10.1038/nmeth1205-902
2.
2.L. Shang, K. Nienhaus, X. Jiang, L. Yang, K. Landfester, V. Mailander, T. Simmet, and G. U. Nienhaus, Beilstein journal of nanotechnology 5, 2388-2397 (2014).
http://dx.doi.org/10.3762/bjnano.5.248
3.
3.WHO, 2007.
4.
4.E. J. Arts and D. J. Hazuda, Cold Spring Harbor perspectives in medicine 2(4), a007161 (2012).
http://dx.doi.org/10.1101/cshperspect.a007161
5.
5.D. S. Fierer and M. E. Klotman, Current opinion in HIV and AIDS 1(2), 115-120 (2006).
6.
6.T. W. Chun, D. C. Nickle, J. S. Justement, J. H. Meyers, G. Roby, C. W. Hallahan, S. Kottilil, S. Moir, J. M. Mican, J. I. Mullins, D. J. Ward, J. A. Kovacs, P. J. Mannon, and A. S. Fauci, The Journal of infectious diseases 197(5), 714-720 (2008).
http://dx.doi.org/10.1086/527324
7.
7.M. Horiike, S. Iwami, M. Kodama, A. Sato, Y. Watanabe, M. Yasui, Y. Ishida, T. Kobayashi, T. Miura, and T. Igarashi, Virology 423(2), 107-118 (2012).
http://dx.doi.org/10.1016/j.virol.2011.11.024
8.
8.H. K. Makadia and S. J. Siegel, Polymers 3(3), 1377-1397 (2011).
http://dx.doi.org/10.3390/polym3031377
9.
9.C. J. Destache, T. Belgum, M. Goede, A. Shibata, and M. A. Belshan, The Journal of antimicrobial chemotherapy 65(10), 2183-2187 (2010).
http://dx.doi.org/10.1093/jac/dkq318
10.
10.G. Sahay, D. Y. Alakhova, and A. V. Kabanov, Journal of controlled release : official journal of the Controlled Release Society 145(3), 182-195 (2010).
http://dx.doi.org/10.1016/j.jconrel.2010.01.036
11.
11.T. Bose, D. Latawiec, P. P. Mondal, and S. Mandal, Journal of Nanoparticle Research 16(8), 1-25 (2014).
http://dx.doi.org/10.1007/s11051-014-2527-7
12.
12.L. Shang, K. Nienhaus, and G. U. Nienhaus, Journal of Nanobiotechnology 12(5), (2014).
http://dx.doi.org/10.1186/1477-3155-12-5
13.
13.H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, International Journal of Pharmaceutics 55(1), R1-R4 (1989).
http://dx.doi.org/10.1016/0378-5173(89)90281-0
14.
14.R. L. McCall and R. W. Sirianni, Journal of visualized experiments : JoVE (82), 51015 (2013).
15.
15.R. Vijayalakshmi, Vadapalli S. H. Naveena, J. Philip, and M. D. Dhanaraju, Der Pharma Chemica 6(1), 404-406 (2014).
16.
16.S. Ghosh, A. Roy, D. Banik, N. Kundu, J. Kuchlyan, A. Dhir, and N. Sarkar, Langmuir : the ACS journal of surfaces and colloids 31(8), 2310-2320 (2015).
http://dx.doi.org/10.1021/la504819v
17.
17.G. Wang, Y. Gong, F. J. Burczynski, and B. B. Hasinoff, Free radical research 42(5), 435-441 (2008).
http://dx.doi.org/10.1080/10715760802074462
18.
18.A. A. Date, A. Shibata, P. Bruck, and C. J. Destache, Biomedical chromatography : BMC 29(5), 709-715 (2015).
http://dx.doi.org/10.1002/bmc.3346
19.
19.D. Ripamonti and F. Maggiolo, Current opinion in investigational drugs (London, England : 2000) 9(8), 899-912 (2008).
20.
20.G. J. Zaharatos and M. A. Wainberg, Annals of medicine 45(3), 236-241 (2013).
http://dx.doi.org/10.3109/07853890.2012.732704
21.
21.F. Danhier, N. Lecouturier, B. Vroman, C. Jerome, J. Marchand-Brynaert, O. Feron, and V. Preat, Journal of controlled release : official journal of the Controlled Release Society 133(1), 11-17 (2009).
http://dx.doi.org/10.1016/j.jconrel.2008.09.086
22.
22.M. M. Yallapu, B. K. Gupta, M. Jaggi, and S. C. Chauhan, Journal of colloid and interface science 351(1), 19-29 (2010).
http://dx.doi.org/10.1016/j.jcis.2010.05.022
23.
23.D. Lawrence, B. Sanders, and O. K. Sharma, in NIH AIDS Reagent Program, Beerse, Belgium (2014).
24.
24.P. P. Mondal and A. Diaspro, in Fundamentals of Fluorescence Microscopy, edited byP. P. Mondal and A. Diaspro (Springer, 2014), Vol. 1, pp. 149-159.
25.
25.J. A. Ankrum, O. R. Miranda, K. S. Ng, D. Sarkar, C. Xu, and J. M. Karp, Nature protocols 9(2), 233-245 (2014).
http://dx.doi.org/10.1038/nprot.2014.002
26.
26.A. Bloom and N. Winograd, Surface and interface analysis : SIA 46(Suppl 1), 177-180 (2014).
http://dx.doi.org/10.1002/sia.5587
27.
27.R. Agarwal, V. Singh, P. Jurney, L. Shi, S. V. Sreenivasan, and K. Roy, Proceedings of the National Academy of Sciences of the United States of America 110(43), 17247-17252 (2013).
http://dx.doi.org/10.1073/pnas.1305000110
http://aip.metastore.ingenta.com/content/aip/journal/adva/5/8/10.1063/1.4926584
Loading
/content/aip/journal/adva/5/8/10.1063/1.4926584
Loading

Data & Media loading...

Loading

Article metrics loading...

/content/aip/journal/adva/5/8/10.1063/1.4926584
2015-07-08
2016-12-08

Abstract

In the last decade, confocal fluorescence microscopy has emerged as an ultra-sensitive tool for real-time study of nanoparticles (NPs) fate at the cellular-level. According to WHO 2007 report, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) is still one of the world’s major health threats by claiming approximately 7,000 new infections daily worldwide. Although combination antiretroviral drugs (cARV) therapy has improved the life-expectancy of HIV-infected patients, routine use of high doses of cARV has serious health consequences and requires complete adherence to the regimen for success. Thus, our research goal is to fabricate long-acting novel cARV loaded poly(lactide-co-glycolic acid) (PLGA) nanoparticles (cARV-NPs) as drug delivery system. However, important aspects of cARV-NPs that require special emphasis are their cellular-uptake, potency, and sustained drug release efficiency over-time. In this article, ultra-sensitive confocal microscopy is been used to evaluate the uptake and sustained drug release kinetics of cARV-NPs in HeLa cells. To evaluate with the above goal, instead of cARV-drug, Rhodamine6G dye (fluorescent dye) loaded NPs (Rho6G NPs) have been formulated. To correlate the Rhodamin6G release kinetics with the ARV release from NPs, a parallel HPLC study was also performed. The results obtained indicate that Rho6G NPs were efficiently taken up at low concentration (<500 ng/ml) and that release was sustained for a minimum of 4 days of treatment. Therefore, high drug assimilation and sustained release properties of PLGA-NPs make them an attractive vehicle for cARV nano-drug delivery with the potential to reduce drug dosage as well as the number of drug administrations per month.

Loading

Full text loading...

/deliver/fulltext/aip/journal/adva/5/8/1.4926584.html;jsessionid=bVCn0AbP0pTIVsKdNiuYyhjv.x-aip-live-06?itemId=/content/aip/journal/adva/5/8/10.1063/1.4926584&mimeType=html&fmt=ahah&containerItemId=content/aip/journal/adva
true
true

Access Key

  • FFree Content
  • OAOpen Access Content
  • SSubscribed Content
  • TFree Trial Content
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
/content/realmedia?fmt=ahah&adPositionList=
&advertTargetUrl=//oascentral.aip.org/RealMedia/ads/&sitePageValue=aipadvances.aip.org/5/8/10.1063/1.4926584&pageURL=http://scitation.aip.org/content/aip/journal/adva/5/8/10.1063/1.4926584'
Right1,Right2,Right3,